{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:50:43Z","timestamp":1781675443287,"version":"3.54.5"},"reference-count":189,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","award":["#309633\/2021-4"],"award-info":[{"award-number":["#309633\/2021-4"]}],"id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2023,8,3]]},"DOI":"10.1080\/14728222.2023.2247559","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T19:43:19Z","timestamp":1693510999000},"page":"679-703","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["New drug targets for the treatment of gout arthritis: what\u2019s new?"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-477X","authenticated-orcid":false,"given":"Tiago H.","family":"Zaninelli","sequence":"first","affiliation":[{"name":"Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Centre of Biological Sciences, Londrina State University, Londrina, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-950X","authenticated-orcid":false,"given":"Geovana","family":"Martelossi-Cebinelli","sequence":"additional","affiliation":[{"name":"Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Centre of Biological Sciences, Londrina State University, Londrina, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-6441","authenticated-orcid":false,"given":"Telma","family":"Saraiva-Santos","sequence":"additional","affiliation":[{"name":"Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Centre of Biological Sciences, Londrina State University, Londrina, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-7505","authenticated-orcid":false,"given":"Sergio M.","family":"Borghi","sequence":"additional","affiliation":[{"name":"Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Centre of Biological Sciences, Londrina State University, Londrina, Paran\u00e1, Brazil"},{"name":"Center for Research in Health Sciences, University of Northern Londrina, Londrina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-7706","authenticated-orcid":false,"given":"Victor","family":"Fattori","sequence":"additional","affiliation":[{"name":"Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Centre of Biological Sciences, Londrina State University, Londrina, Paran\u00e1, Brazil"},{"name":"Vascular Biology Program, Department of Surgery, Boston Children\u2019s Hospital-Harvard Medical School, Karp Research Building, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-1668","authenticated-orcid":false,"given":"Rubia","family":"Casagrande","sequence":"additional","affiliation":[{"name":"Laboratory of Antioxidants and Inflammation, Department of Pharmaceutical Sciences, Centre of Health Sciences, Londrina State University, Londrina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-9283","authenticated-orcid":false,"suffix":"Jr","given":"Waldiceu A.","family":"Verri","sequence":"additional","affiliation":[{"name":"Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Centre of Biological Sciences, Londrina State University, Londrina, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.91"},{"issue":"10055","key":"e_1_3_6_3_1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth N","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 30;388(10055):2039\u20132052.","journal-title":"Lancet"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2016.01.030"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.06.005"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00001"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10792"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M800737200"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab327"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219796"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60883-7"},{"key":"e_1_3_6_14_1","first-page":"1919","article-title":"Lower temperatures exacerbate NLRP3 inflammasome activation by promoting monosodium urate crystallization","volume":"10","author":"Ahn H","year":"2021","unstructured":"Ahn H, Lee G, Lee GS. Lower temperatures exacerbate NLRP3 inflammasome activation by promoting monosodium urate crystallization. Causing Gout. 2021;10:1919 .","journal-title":"Causing Gout"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10274"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402195"},{"issue":"11","key":"e_1_3_6_17_1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So AK","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol [Internet]. 2017 Sep 30;13(11):639\u2013647. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28959043","journal-title":"Nat Rev Rheumatol"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38369"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27667"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02508-9"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10759"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.277"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3333"},{"key":"e_1_3_6_24_1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00011-020-01399-x","article-title":"IL-33 enhances macrophage release of IL-1\u03b2 and promotes pain and inflammation in gouty arthritis","volume":"69","author":"Fattori V","year":"2020","unstructured":"Fattori V, Staurengo-Ferrari L, Zaninelli TH, et al. IL-33 enhances macrophage release of IL-1\u03b2 and promotes pain and inflammation in gouty arthritis. Inflamm Res. [Internet]. 2020 [cited 2022 Jul 31];69:1271\u20131282. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32886146\/","journal-title":"Inflamm Res"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545605"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122655"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3370"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.02.166"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0052-y"},{"issue":"5","key":"e_1_3_6_30_1","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1046\/j.1471-4159.1999.02206.x","article-title":"Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system","volume":"73","author":"Inoue A","year":"1999","unstructured":"Inoue A, Ikoma K, Morioka N, et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem. 1999;73(5):2206\u20132213.","journal-title":"J Neurochem"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/35068566"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2015.04.025"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.03.025"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.04.021"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1351945"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57010058"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.01.013"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.04.010"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27356"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-2136-z"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2007-7"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-019-0103-y"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1860-8"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55010008"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2019.10.002"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114460"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-017-0356-x"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-2009-9809"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/528018"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b00959"},{"key":"e_1_3_6_51_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01123","article-title":"Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in Mice","volume":"9","author":"Staurengo-Ferrari L","year":"2018","unstructured":"Staurengo-Ferrari L, Ruiz-Miyazawa KW, Pinho-Ribeiro FA, et al. Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in Mice. Front Pharmacol. [Internet]. 2018 [cited 2022 Nov 15];9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30333752\/","journal-title":"Front Pharmacol"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2018.06.025"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2012.06.012"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.08.063"},{"key":"e_1_3_6_55_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01076","article-title":"Budlein A, a Sesquiterpene lactone from viguiera robusta, alleviates pain and inflammation in a model of acute gout arthritis in Mice","volume":"9","author":"Fattori V","year":"2018","unstructured":"Fattori V, Zarpelon AC, Staurengo-Ferrari L, et al. Budlein A, a Sesquiterpene lactone from viguiera robusta, alleviates pain and inflammation in a model of acute gout arthritis in Mice. Front Pharmacol. [Internet]. 2018 [cited 2022 Jul 31];9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30319413\/","journal-title":"Front Pharmacol"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113738"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115291"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.12.031"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108107"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.837182"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S320912"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114778"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-013-0602-7"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1676-4371"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1033520"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01076-x"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205739"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6950206"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2969364"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.0c03848"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00955"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.10.023"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-017-1955-1"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9456318"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5526"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.3390\/plants10020278"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2021.06.009"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.993951"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940228"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1023453"},{"key":"e_1_3_6_81_1","doi-asserted-by":"crossref","unstructured":"Zaninelli TH Fattori V Saraiva\u2010Santos T et al. RvD1 disrupts nociceptor neuron and macrophage activation and neuroimmune communication reducing pain and inflammation in gouty arthritis in mice. Br J Pharmacol [Internet]. 2022. [cited 2022 Jul 31]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35716378\/.","DOI":"10.1111\/bph.15897"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01014-x"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9241835"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac009"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5541232"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S351660"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00710"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.979939"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181685"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3317307"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1974-z"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041071"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-20-0305"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153521"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X19500071"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.023"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-021-01571-5"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.12.006"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16036"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1652244"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.651305"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.46153"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep41539"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep38622"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7514"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.orglett.6b03435"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102696"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200465"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2022.03.003"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104348"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33355"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3MA0915-418R"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104351"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00010"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez384"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MA1118-470RR"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580593"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S356307"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12868"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201516"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.549"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13587"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01483-2"},{"key":"e_1_3_6_124_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00011-021-01439-0","article-title":"Tripterine ameliorates monosodium urate crystal-induced gouty arthritis by altering macrophage polarization via the miR-449a\/NLRP3 axis","volume":"70","author":"Wang Y","year":"2021","unstructured":"Wang Y. Tripterine ameliorates monosodium urate crystal-induced gouty arthritis by altering macrophage polarization via the miR-449a\/NLRP3 axis. Inflamm Res. [Internet]. 2021 [cited 2023 Jun 11]; 70:323\u2013341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33559709\/","journal-title":"Inflamm Res"},{"key":"e_1_3_6_125_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jep.2014.12.001","article-title":"Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice","volume":"161","author":"Sun WF","year":"2015","unstructured":"Sun WF, Zhu MM, Li J, et al. Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice. J Ethnopharmacol. [Internet]. 2015 [cited 2023 Jun 11]; 161:163\u2013169. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25535087\/","journal-title":"J Ethnopharmacol"},{"key":"e_1_3_6_126_1","doi-asserted-by":"crossref","first-page":"111413","DOI":"10.1016\/j.biopha.2021.111413","article-title":"Total glucosides of paeony protects THP-1 macrophages against monosodium urate-induced inflammation via MALAT1\/miR-876-5p\/NLRP3 signaling cascade in gouty arthritis","volume":"138","author":"Meng Q","year":"2021","unstructured":"Meng Q, Meng W, Bian H, et al. Total glucosides of paeony protects THP-1 macrophages against monosodium urate-induced inflammation via MALAT1\/miR-876-5p\/NLRP3 signaling cascade in gouty arthritis. Biomed Pharmacother. [Internet]. 2021 [cited 2023 Jun 11]; 138:111413. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33677310\/","journal-title":"Biomed Pharmacother"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1874696"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14028"},{"issue":"1","key":"e_1_3_6_129_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1418-6","article-title":"MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis","volume":"19","author":"Zhou W","year":"2017","unstructured":"Zhou W, Wang Y, Wu R, et al. MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis. Arthritis Res Ther. [Internet]. 2017 [cited 2023 Jun 11]; 19(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28915828\/","journal-title":"Arthritis Res Ther"},{"key":"e_1_3_6_130_1","first-page":"9230","article-title":"MiR-146a alleviates inflammation of acute gouty arthritis rats through TLR4\/MyD88 signal transduction pathway","volume":"23","author":"Chen X","year":"2019","unstructured":"Chen X, Gao Q, Zhou L, et al. MiR-146a alleviates inflammation of acute gouty arthritis rats through TLR4\/MyD88 signal transduction pathway. Eur Rev Med Pharmacol Sci. [Internet]. 2019 [cited 2023 Jun 11]; 23:9230\u20139237. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31773674\/","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"e_1_3_6_131_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1546-7","article-title":"Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome","volume":"20","author":"Zhang QB","year":"2018","unstructured":"Zhang QB, Qing YF, Yin CC, et al. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome. Arthritis Res Ther [Internet]. 2018 [cited 2023 Jun 11]; 20(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29544526\/","journal-title":"Arthritis Res Ther"},{"key":"e_1_3_6_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32334-0"},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646551"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105445"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38112"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220295"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1159\/000505934"},{"issue":"10","key":"e_1_3_6_138_1","article-title":"[Ru(bpy) 2(NO)SO 3](PF 6), a nitric oxide donating ruthenium complex, Reduces gout arthritis in Mice","volume":"10","author":"Rossaneis AC","year":"2019","unstructured":"Rossaneis AC, Longhi-Balbinot DT, Bertozzi MM, et al. [Ru(bpy) 2(NO)SO 3](PF 6), a nitric oxide donating ruthenium complex, Reduces gout arthritis in Mice. Front Pharmacol [Internet]. 2019 [cited 2022 Jul 31]; 10(10. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30914954\/","journal-title":"Front Pharmacol"},{"issue":"5","key":"e_1_3_6_139_1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi Y","year":"2014","unstructured":"Choi Y, Yu A-M. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des. [Internet]. 2014 [cited 2023 Jun 2]; 20(5):793\u2013807. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23688078\/","journal-title":"Curr Pharm Des"},{"key":"e_1_3_6_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.05.002"},{"key":"e_1_3_6_141_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370219830665"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/jcmrd0"},{"key":"e_1_3_6_143_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4365"},{"key":"e_1_3_6_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.04.007"},{"key":"e_1_3_6_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-015-3258-5"},{"key":"e_1_3_6_146_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01283"},{"key":"e_1_3_6_147_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00467"},{"key":"e_1_3_6_148_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591803"},{"key":"e_1_3_6_149_1","first-page":"12","article-title":"Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases","volume":"34","author":"Zhong Z","year":"2016","unstructured":"Zhong Z, Sanchez-Lopez E, Karin M. Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases. Clin Exp Rheumatol. 2016;34:12\u201316.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_150_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-62703-523-1_8","article-title":"ASC speck formation as a readout for inflammasome activation","volume":"1040","author":"Stutz A","year":"2013","unstructured":"Stutz A, Horvath GL, Monks BG, et al. ASC speck formation as a readout for inflammasome activation. Methods Mol Biol. 2013;1040:91\u2013101.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_6_151_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800973"},{"key":"e_1_3_6_152_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122655"},{"key":"e_1_3_6_153_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444560"},{"key":"e_1_3_6_154_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914733107"},{"key":"e_1_3_6_155_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-10"},{"key":"e_1_3_6_156_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12606"},{"key":"e_1_3_6_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102103"},{"key":"e_1_3_6_158_1","doi-asserted-by":"crossref","unstructured":"Morrison H. Enzyme Active Sites and their Reaction Mechanisms. 1st ed. Elsevier; 2021. p. 173\u2013178.","DOI":"10.1016\/B978-0-12-821067-3.00029-5"},{"key":"e_1_3_6_159_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3538"},{"key":"e_1_3_6_160_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402"},{"key":"e_1_3_6_161_1","article-title":"Role of microRNA alternation in the pathogenesis of gouty arthritis","volume":"13","author":"Luo Z","year":"2022","unstructured":"Luo Z, Yang F, Hong S, et al. Role of microRNA alternation in the pathogenesis of gouty arthritis. Front Endocrinol. [Internet]. 2022 [cited 2023 Jun 6]; 13. Available from: \/pmc\/articles\/PMC9402903\/","journal-title":"Front Endocrinol"},{"key":"e_1_3_6_162_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781815"},{"key":"e_1_3_6_163_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13156"},{"key":"e_1_3_6_164_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01286-3"},{"key":"e_1_3_6_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13479"},{"key":"e_1_3_6_166_1","doi-asserted-by":"crossref","unstructured":"Fattori V Zaninelli TH Rasquel-Oliveira FS et al. Specialized pro-resolving lipid mediators: a new class of non-immunosuppressive and non-opioid analgesic drugs [Internet]. [2020 Jan 1]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31743775\/.","DOI":"10.1016\/j.phrs.2019.104549"},{"key":"e_1_3_6_167_1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fphys.2021.729134","article-title":"Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators\u2019 contribution to arthritis physiopathology and future perspectives","volume":"12","author":"Zaninelli TH","year":"2021","unstructured":"Zaninelli TH, Fattori V, Verri W. Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators\u2019 contribution to arthritis physiopathology and future perspectives. Front Physiol. [Internet].2021 [cited 2021 Oct 16]; 12:1444. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34539449\/","journal-title":"Front Physiol"},{"key":"e_1_3_6_168_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7242030"},{"key":"e_1_3_6_169_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.32"},{"key":"e_1_3_6_170_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.1.31"},{"key":"e_1_3_6_171_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket352"},{"issue":"3","key":"e_1_3_6_172_1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/ph16030343","article-title":"Kaurenoic acid Reduces ongoing chronic constriction injury-induced neuropathic pain: nitric oxide silencing of dorsal root ganglia neurons","volume":"16","author":"Zaninelli TH","year":"2023","unstructured":"Zaninelli TH, Mizokami SS, Bertozzi MM, et al. Kaurenoic acid Reduces ongoing chronic constriction injury-induced neuropathic pain: nitric oxide silencing of dorsal root ganglia neurons. Pharmaceuticals. [Internet]. 2023 [cited 2023 Mar 7]; 16(3):343. Available from: https:\/\/www.mdpi.com\/1424-8247\/16\/3\/343\/htm","journal-title":"Pharmaceuticals"},{"key":"e_1_3_6_173_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-444-63601-0.00007-7","article-title":"Sesquiterpene lactones: structural diversity and perspectives as anti-inflammatory molecules","volume":"49","author":"Hohmann MSN","year":"2016","unstructured":"Hohmann MSN, Longhi-Balbinot DT, Guazelli CFS, et al. Sesquiterpene lactones: structural diversity and perspectives as anti-inflammatory molecules. Stud Nat Prod Chem. 2016;49:243\u2013264.","journal-title":"Stud Nat Prod Chem"},{"key":"e_1_3_6_174_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25030762"},{"key":"e_1_3_6_175_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140612780"},{"key":"e_1_3_6_176_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-015-0183-5"},{"key":"e_1_3_6_177_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.571994"},{"key":"e_1_3_6_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706012"},{"key":"e_1_3_6_179_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721815115"},{"key":"e_1_3_6_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92785-4"},{"key":"e_1_3_6_181_1","doi-asserted-by":"publisher","DOI":"10.1159\/000136556"},{"key":"e_1_3_6_182_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42009"},{"key":"e_1_3_6_183_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-022-2416-1"},{"key":"e_1_3_6_184_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152908"},{"key":"e_1_3_6_185_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.935723"},{"key":"e_1_3_6_186_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261940"},{"key":"e_1_3_6_187_1","doi-asserted-by":"publisher","DOI":"10.1080\/19390211.2022.2107138"},{"issue":"26","key":"e_1_3_6_188_1","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2174\/1568026617666170821124947","article-title":"Update on COX-2 selective Inhibitors: chemical classification, side effects and their use in cancers and neuronal diseases","volume":"17","author":"Rayar AM","year":"2017","unstructured":"Rayar AM, Lagarde N, Ferroud C, et al. Update on COX-2 selective Inhibitors: chemical classification, side effects and their use in cancers and neuronal diseases. Curr Top Med Chem [Internet]. 2017 Aug 23;17(26):2935\u20132956. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28828990","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"e_1_3_6_189_1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2018.04.006","article-title":"Blocking neuronal signaling to immune cells treats streptococcal invasive infection","volume":"173","author":"Pinho-Ribeiro FA","year":"2018","unstructured":"Pinho-Ribeiro FA, Baddal B, Haarsma R, et al. Blocking neuronal signaling to immune cells treats streptococcal invasive infection. Cell. [Internet]. 2018 [cited 2021 Mar 22]; 173(5):1083\u20131097 e22. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29754819","journal-title":"Cell"},{"issue":"2","key":"e_1_3_6_190_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-021-00973-8","article-title":"Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons","volume":"25","author":"Yang NJ","year":"2022","unstructured":"Yang NJ, Isensee J, Neel DV, et al. Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons. Nat Neurosci. 2022;25(2):168\u2013179. Internet. [cited 2023 Jun 6]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34931070\/","journal-title":"Nat Neurosci"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2023.2247559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T19:28:04Z","timestamp":1703100484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728222.2023.2247559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":189,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,3]]}},"alternative-id":["10.1080\/14728222.2023.2247559"],"URL":"https:\/\/doi.org\/10.1080\/14728222.2023.2247559","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}